AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
349 hedge funds and large institutions have $4.17B invested in Amedisys in 2021 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 120 increasing their positions, 122 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $51.4M
41% less capital invested
Capital invested by funds: $7.06B → $4.17B (-$2.9B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
349
Holding in Top 10
–
Calls
$35.1M
Puts
$51.4M
Top Buyers
| 1 | +$67M | |
| 2 | +$58.1M | |
| 3 | +$48.4M | |
| 4 |
D.E. Shaw & Co
New York
|
+$40.6M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$36.1M |
Top Sellers
| 1 | -$121M | |
| 2 | -$70.9M | |
| 3 | -$66.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$58.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$52.3M |